<VariationArchive VariationID="2857106" VariationName="NM_152383.5(DIS3L2):c.796_799dup (p.Leu267fs)" VariationType="Duplication" Accession="VCV002857106" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3014325" VariationID="2857106">
      <GeneList>
        <Gene Symbol="DIS3L2" FullName="DIS3 like 3'-5' exoribonuclease 2" GeneID="129563" HGNC_ID="HGNC:28648" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q37.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="231961713" stop="232344350" display_start="231961713" display_stop="232344350" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="232826292" stop="233208677" display_start="232826292" display_stop="233208677" Strand="+" />
          </Location>
          <OMIM>614184</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DIS3L2">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DIS3L2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_152383.5(DIS3L2):c.796_799dup (p.Leu267fs)</Name>
      <CanonicalSPDI>NC_000002.12:232136563:CGCCC:CGCCCGCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q37.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="232136563" stop="232136564" display_start="232136563" display_stop="232136564" variantLength="4" positionVCF="232136563" referenceAlleleVCF="A" alternateAlleleVCF="ACGCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="233001273" stop="233001274" display_start="233001273" display_stop="233001274" variantLength="4" positionVCF="233001273" referenceAlleleVCF="A" alternateAlleleVCF="ACGCC" />
      </Location>
      <ProteinChange>L267fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_534" sequenceAccession="LRG_534">
            <Expression>LRG_534:g.179983_179986dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_534t1" sequenceAccession="LRG_534t1">
            <Expression>LRG_534t1:c.796_799dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_534p1" sequenceAccession="LRG_534p1" change="p.Leu267Argfs">
            <Expression>LRG_534p1:p.Leu267Argfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.233001275_233001278dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.233001275_233001278dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.232136565_232136568dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.232136565_232136568dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032572.1" sequenceAccession="NG_032572" sequenceVersion="1" change="g.179983_179986dup">
            <Expression>NG_032572.1:g.179983_179986dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001257281.2" sequenceAccession="NM_001257281" sequenceVersion="2" change="c.796_799dup">
            <Expression>NM_001257281.2:c.796_799dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001244210.1" sequenceAccession="NP_001244210" sequenceVersion="1" change="p.Leu267fs">
            <Expression>NP_001244210.1:p.Leu267fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152383.5" sequenceAccession="NM_152383" sequenceVersion="5" change="c.796_799dup" MANESelect="true">
            <Expression>NM_152383.5:c.796_799dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689596.4" sequenceAccession="NP_689596" sequenceVersion="4" change="p.Leu267fs">
            <Expression>NP_689596.4:p.Leu267fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_046476.2" sequenceAccession="NR_046476" sequenceVersion="2" change="n.942_945dup">
            <Expression>NR_046476.2:n.942_945dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_152383.5(DIS3L2):c.796_799dup (p.Leu267fs) AND Perlman syndrome" Accession="RCV003644323" Version="1">
        <ClassifiedConditionList TraitSetID="7919">
          <ClassifiedCondition DB="MedGen" ID="C0796113">Perlman syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22306653</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28328139</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7919" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5853" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Renal hamartomas nephroblastomatosis and fetal gigantism</ElementValue>
                <XRef ID="Renal+hamartomas+nephroblastomatosis+and+fetal+gigantism/6206" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Perlman syndrome</ElementValue>
                <XRef ID="MONDO:0009965" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephroblastomatosis fetal ascites macrosomia and wilms tumor</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PRLMNS</ElementValue>
                <XRef Type="MIM" ID="267000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3936" />
                <XRef ID="3936" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <XRef ID="2849" DB="Orphanet" />
              <XRef ID="C0796113" DB="MedGen" />
              <XRef ID="MONDO:0009965" DB="MONDO" />
              <XRef Type="MIM" ID="267000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8246101" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="21426464|MedGen:C0796113" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004458299" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22306653</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28328139</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu267Argfs*12) in the DIS3L2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DIS3L2 are known to be pathogenic (PMID: 22306653, 28328139). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with DIS3L2-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DIS3L2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.233001273_233001274insCGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796113" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8246101" TraitType="Disease" MappingType="XRef" MappingValue="C0796113" MappingRef="MedGen">
        <MedGen CUI="C0796113" Name="Perlman syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

